Reply to Dr Yucel's Comments on the Article “Long-term Outcome of Clozapine in Treatment-Resistant Schizophrenia”-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reply to Dr Yucel's Comments on the Article “Long-term Outcome of Clozapine in Treatment-Resistant Schizophrenia”

Published:2023-11 Issue:6 Volume:43 Page:555-556
ISSN:1533-712X
Container-title:Journal of Clinical Psychopharmacology
language:en
Short-container-title:J Clin Psychopharmacol

Author:

Lee Myung A.,Cola Philip,Jayathilake Karu,Meltzer Herbert Y.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference11 articles.

1. Critical feedback on article by Lee and colleagues for “Long-Term outcome of clozapine in treatment-resistant schizophrenia”;J Clin Psychopharmacol,2023

2. Long-term outcome of clozapine in treatment-resistant schizophrenia;J Clin Psychopharmacol,2023

3. Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis;Br J Psychiatry,2016

4. Efficacy and safety of clozapine in psychotic disorders-a systematic quantitative meta-review;Transl Psychiatry,2021

5. The side effect profile of clozapine in real world data of three large mental health hospitals;PloS One,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP